Percentage of Semaglutide Users Reporting Vision Loss or Partial Blindness Study results indicate an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION) in patients using semaglutide for Type 2 diabetes and obesity
51 Park et al 52 found that empagliflozin, dulaglutide and a combination of both significantly attenuated the increase in cells, especially macrophages and neutrophils, in airway alveolar lavage fluid induced by a high-fat diet in mice, reduced the expression of IL-17 and transforming growth factor (TGF)-1, and decreased the differentiation of Th cells to Th1 and Th17, thereby achieving a reduced inflammatory response
This two-vial-size approach covers the entire protocol with minimal reconstitution math
TRESIBA is not for people with diabetic ketoacidosis (increased ketones in the blood or urine)
In people with reduced ADAMTS13 enzyme activity, factors such as pregnancy, surgery, and infection may trigger abnormal blood clotting and its associated complications
If you're trying to decide which one is better, the real answer is: it depends
